Return On Equity of DEXCOM INC from 31 Mar 2012 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
DEXCOM INC quarterly and annual Return On Equity in % history and change rate from 31 Mar 2012 to 30 Jun 2024.
  • DEXCOM INC Return On Equity for the quarter ending 30 Jun 2024 was 30%, a 71% increase year-over-year.
  • DEXCOM INC annual Return On Equity for 2023 was 25%, a 54% increase from 2022.
  • DEXCOM INC annual Return On Equity for 2022 was 16%, a 51% increase from 2021.
  • DEXCOM INC annual Return On Equity for 2021 was 11%, a 73% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

DEXCOM INC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 30% +12% +71% 01 Apr 2024 30 Jun 2024
Q1 2024 29% +16% +113% 01 Jan 2024 31 Mar 2024
Q4 2023 25% +8.7% +54% 01 Oct 2023 31 Dec 2023
Q3 2023 17% +5.5% +47% 01 Jul 2023 30 Sep 2023
Q2 2023 17% +6.6% +62% 01 Apr 2023 30 Jun 2023
Q1 2023 14% +1.5% +12% 01 Jan 2023 31 Mar 2023
Q4 2022 16% +5.5% +51% 01 Oct 2022 31 Dec 2022
Q3 2022 12% -20% -64% 01 Jul 2022 30 Sep 2022
Q2 2022 11% -24% -69% 01 Apr 2022 30 Jun 2022
Q1 2022 12% -23% -65% 01 Jan 2022 31 Mar 2022
Q4 2021 11% -28% -73% 01 Oct 2021 31 Dec 2021
Q3 2021 32% +12% +63% 01 Jul 2021 30 Sep 2021
Q2 2021 34% +13% +64% 01 Apr 2021 30 Jun 2021
Q1 2021 36% +18% +97% 01 Jan 2021 31 Mar 2021
Q4 2020 39% +26% +191% 01 Oct 2020 31 Dec 2020
Q3 2020 20% +44% 01 Jul 2020 30 Sep 2020
Q2 2020 21% +47% 01 Apr 2020 30 Jun 2020
Q1 2020 18% +40% 01 Jan 2020 31 Mar 2020
Q4 2019 13% +37% 01 Oct 2019 31 Dec 2019
Q3 2019 -25% -34% -368% 01 Jul 2019 30 Sep 2019
Q2 2019 -26% -25% -1987% 01 Apr 2019 30 Jun 2019
Q1 2019 -22% -14% -164% 01 Jan 2019 31 Mar 2019
Q4 2018 -24% -9.9% -71% 01 Oct 2018 31 Dec 2018
Q3 2018 9.2% +24% 01 Jul 2018 30 Sep 2018
Q2 2018 -1.3% +21% +94% 01 Apr 2018 30 Jun 2018
Q1 2018 -8.3% +25% +75% 01 Jan 2018 31 Mar 2018
Q4 2017 -14% +12% +45% 01 Oct 2017 31 Dec 2017
Q3 2017 -15% +8.8% +37% 01 Jul 2017 30 Sep 2017
Q2 2017 -22% +14% +39% 01 Apr 2017 30 Jun 2017
Q1 2017 -33% -1.6% -5.2% 01 Jan 2017 31 Mar 2017
Q4 2016 -26% +5.8% +18% 01 Oct 2016 31 Dec 2016
Q3 2016 -24% +12% +33% 01 Jul 2016 30 Sep 2016
Q2 2016 -36% -22% -153% 01 Apr 2016 30 Jun 2016
Q1 2016 -31% -13% -73% 01 Jan 2016 31 Mar 2016
Q4 2015 -31% -11% -56% 01 Oct 2015 31 Dec 2015
Q3 2015 -35% -8.4% -31% 01 Jul 2015 30 Sep 2015
Q2 2015 -14% +17% +54% 01 Apr 2015 30 Jun 2015
Q1 2015 -18% +21% +53% 01 Jan 2015 31 Mar 2015
Q4 2014 -20% +19% +49% 01 Oct 2014 31 Dec 2014
Q3 2014 -27% +21% +44% 01 Jul 2014 30 Sep 2014
Q2 2014 -31% +31% +50% 01 Apr 2014 30 Jun 2014
Q1 2014 -39% +25% +39% 01 Jan 2014 31 Mar 2014
Q4 2013 -39% +24% +38% 01 Oct 2013 31 Dec 2013
Q3 2013 -48% +14% +23% 01 Jul 2013 30 Sep 2013
Q2 2013 -62% -8.8% -17% 01 Apr 2013 30 Jun 2013
Q1 2013 -64% -21% -49% 01 Jan 2013 31 Mar 2013
Q4 2012 -63% 01 Oct 2012 31 Dec 2012
Q3 2012 -62% 01 Jul 2012 30 Sep 2012
Q2 2012 -53% 01 Apr 2012 30 Jun 2012
Q1 2012 -43% 01 Jan 2012 31 Mar 2012

DEXCOM INC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 25% +8.7% +54% 01 Jan 2023 31 Dec 2023
2022 16% +5.5% +51% 01 Jan 2022 31 Dec 2022
2021 11% -28% -73% 01 Jan 2021 31 Dec 2021
2020 39% +26% +191% 01 Jan 2020 31 Dec 2020
2019 13% +37% 01 Jan 2019 31 Dec 2019
2018 -24% -9.9% -71% 01 Jan 2018 31 Dec 2018
2017 -14% +12% +45% 01 Jan 2017 31 Dec 2017
2016 -26% +5.8% +18% 01 Jan 2016 31 Dec 2016
2015 -31% -11% -56% 01 Jan 2015 31 Dec 2015
2014 -20% +19% +49% 01 Jan 2014 31 Dec 2014
2013 -39% +24% +38% 01 Jan 2013 31 Dec 2013
2012 -63% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.